1.
|
Ascione R, Lloyd CT, Underwood MJ, Lotto
AA, Pitsis AA and Angelini GD: Inflammatory response after coronary
revascularization with or without cardiopulmonary bypass. Ann
Thorac Surg. 69:1198–1204. 2000. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Paparella D, Cappabianca G, Malvindi P, et
al: Myocardial injury after off-pump coronary artery bypass
grafting operation. Eur J Cardiothorac Surg. 32:481–487. 2007.
View Article : Google Scholar : PubMed/NCBI
|
3.
|
Motallebzadeh R and Kanagasabay RR:
Additional uses of stabilization devices in cardiac surgery. Ann
Thorac Surg. 2212:author reply. 2212–2213. 2004. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Ketenci B, Enc Y, Ozay B, et al:
Myocardial injury during off-pump surgery. The effect of
intraoperative risk factors. Saudi Med J. 29:203–208.
2008.PubMed/NCBI
|
5.
|
Karu I, Tähepõld P, Sulling TA, Alver M,
Zilmer M and Starkopf J: Off-pump coronary surgery causes immediate
release of myocardial damage markers. Asian Cardiovasc Thorac Ann.
17:494–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Tok M, Ucar HI, Dogan OF, Farsak B and
Yorgancioglu AC: Protective role of intracoronary shunt in off-pump
coronary bypass operations. Saudi Med J. 29:573–579.
2008.PubMed/NCBI
|
7.
|
Wei M, Jian K, Guo Z, et al: Effects of
half-dose aprotinin in off-pump coronary artery bypass grafting.
World J Surg. 30:1108–1114. 2006. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Woo YJ, Grand TJ, Zentko S, et al:
Creatine phosphate administration preserves myocardial function in
a model of off-pump coronary revascularization. J Cardiovasc Surg
(Torino). 46:297–305. 2005.PubMed/NCBI
|
9.
|
Wallace AW: Clonidine and modification of
perioperative outcome. Curr Opin Anaesthesiol. 19:411–417. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10.
|
Myles PS, Hunt JO, Holdgaard HO, et al:
Clonidine and cardiac surgery: haemodynamic and metabolic effects,
myocardial ischaemia and recovery. Anaesth Intensive Care.
27:137–147. 1999.PubMed/NCBI
|
11.
|
Anand RS, Ochroch FA and Neligan PJ:
Alpha-2-adrenoceptor agonist therapy in perioperative medicine and
critical care. Contemp Crit Care. 2:1–11. 2005.
|
12.
|
Muller S, Borowics SM, Fortis EA, et al:
Clinical efficacy of dexmedetomidine alone is less than propofol
for conscious sedation during ERCP. Gastrointest Endosc.
67:651–659. 2008. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Yildiz M, Tavlan A, Tuncer S, Reisli R,
Yosunkaya A and Otelcioglu S: Effect of dexmedetomidine on
haemodynamic responses to laryngoscopy and intubation:
perioperative haemodynamics and anaesthetic requirements. Drugs R
D. 7:43–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Chalikonda SA: Alpha2-adrenergic agonists
and their role in the prevention of perioperative adverse cardiac
events. AANA J. 77:103–108. 2009.PubMed/NCBI
|
15.
|
Jalonen J, Hynynen M, Kuitunen A, et al:
Dexmedetomidine as an anesthetic adjunct in coronary artery bypass
grafting. Anesthesiology. 86:331–345. 1997. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Hosokawa K, Shime N, Kato Y, et al:
Dexmedetomidine sedation in children after cardiac surgery. Pediatr
Crit Care Med. 11:39–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Dasta JF, Jacobi J, Sesti AM and
McLaughlin TP: Addition of dexmedetomidine to standard sedation
regimens after cardiac surgery: an outcomes analysis.
Pharmacotherapy. 26:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Chrysostomou C, Beerman L, Shiderly D,
Berry D, Morell VO and Munoz R: Dexmedetomidine: a novel drug for
the treatment of atrial and junctional tachyarrhythmias during the
perioperative period for congenital cardiac surgery: a preliminary
study. Anesth Analg. 107:1514–1522. 2008. View Article : Google Scholar
|
19.
|
Ruesch S and Levy JH: Treatment of
persistent tachycardia with dexmedetomidine during off-pump cardiac
surgery. Anesth Analg. 95:316–318. 2002.PubMed/NCBI
|
20.
|
Ohsugi E, Nagamine Y and Ohtsuka M: The
effect of dexmedetomidine in a child with intractable
supraventricular tachyarrythmia after total cavopulmonary
connection. Masui. 60:493–495. 2011.(In Japanese).
|
21.
|
Fellahi JL, Gué X, Richomme X, Monier E,
Guillou L and Riou B: Short- and long-term prognostic value of
postoperative cardiac troponin I concentration in patients
undergoing coronary artery bypass grafting. Anesthesiology.
99:270–274. 2003. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Lasocki S, Provenchère S, Bénessiano J, et
al: Cardiac troponin I is an independent predictor of in-hospital
death after adult cardiac surgery. Anesthesiology. 97:405–411.
2002. View Article : Google Scholar : PubMed/NCBI
|
23.
|
van Geene Y, van Swieten HA and Noyez L:
Cardiac troponin I levels after cardiac surgery as predictor for
in-hospital mortality. Interact Cardiovasc Thorac Surg. 10:413–416.
2010.PubMed/NCBI
|
24.
|
Tempe DK, Dutta D, Garg M, Minhas H, Tomar
A and Virmani S: Myocardial protection with isoflurane during
off-pump coronary artery bypass grafting: a randomized trial. J
Cardiothorac Vasc Anesth. 25:59–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
25.
|
Vanden Eynden F, Cartier R, Marcheix B,
Demers P and Bouchard D: Prognosis of perioperative myocardial
infarction after off-pump coronary artery bypass surgery. J
Cardiovasc Surg (Torino). 50:535–543. 2009.PubMed/NCBI
|
26.
|
Selvanayagam JB, Petersen SE, Francis JM,
et al: Effects of off-pump versus on-pump coronary surgery on
reversible and irreversible myocardial injury: a randomized trial
using cardiovascular magnetic resonance imaging and biochemical
markers. Circulation. 109:345–350. 2004. View Article : Google Scholar
|
27.
|
Kurita A and Shintani H: Risk factors for
myocardial injury during off-pump coronary artery bypass grafting.
Heart Surg Forum. 8:E401–E405. 2005. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Gerlach AT and Dasta JF: Dexmedetomidine:
an updated review. Ann Pharmacother. 41:245–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
29.
|
Dasta JF, Kane-Gill SL and Durtschi AJ:
Comparing dexmedetomidine prescribing patterns and safety in the
naturalistic setting versus published data. Ann Pharmacother.
38:1130–1135. 2004. View Article : Google Scholar : PubMed/NCBI
|
30.
|
Willigers HM, Prinzen FW and Roekaerts PM:
Comparison of the effects of dexmedetomidine and esmolol on
myocardial oxygen consumption in dogs. Eur J Anaesthesiol.
21:957–966. 2004. View Article : Google Scholar : PubMed/NCBI
|
31.
|
Snapir A, Posti J, Kentala E, et al:
Effects of low and high plasma concentrations of dexmedetomidine on
myocardial perfusion and cardiac function in healthy male subjects.
Anesthesiolog. 105:902–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
32.
|
Baumgart D, Haude M, Görge G, et al:
Augmented alpha-adrenergic constriction of atherosclerotic human
coronary arteries. Circulation. 99:2090–2097. 1999. View Article : Google Scholar : PubMed/NCBI
|
33.
|
Penttilä J, Helminen A, Anttila M, Hinkka
S and Scheinin H: Cardiovascular and parasympathetic effects of
dexmedetomidine in healthy subjects. Can J Physiol Pharmacol.
82:359–362. 2004.PubMed/NCBI
|
34.
|
Ebert TJ, Hall JE, Barney JA, Uhrich TD
and Colinco MD: The effects of increasing plasma concentrations of
dexmedetomidine in humans. Anesthesiology. 93:382–394. 2000.
View Article : Google Scholar : PubMed/NCBI
|
35.
|
Rastan AJ, Bittner HB, Gummert JF, et al:
On-pump beating heart versus off-pump coronary artery bypass
surgery-evidence of pump-induced myocardial injury. Eur J
Cardiothorac Surg. 27:1057–1064. 2005. View Article : Google Scholar : PubMed/NCBI
|
36.
|
Kalisnik JM, Avbelj V, Trobec R, et al:
Assessment of cardiac autonomic regulation and ventricular
repolarization after off-pump coronary artery bypass grafting.
Heart Surg Forum. 9:E661–E667. 2006. View Article : Google Scholar : PubMed/NCBI
|
37.
|
Kalman JM, Munawar M, Howes LG, et al:
Atrial fibrillation after coronary artery bypass grafting is
associated with sympathetic activation. Ann Thorac Surg.
60:1709–1715. 1995. View Article : Google Scholar : PubMed/NCBI
|
38.
|
Chrysostomou C, Beerman L, Shiderly D,
Berry D, Morell VO and Munoz R: Dexmedetomidine: a novel drug for
the treatment of atrial and junctional tachyarrhythmias during the
perioperative period for congenital cardiac surgery: a preliminary
study. Anesth Analg. 107:1514–1522. 2008. View Article : Google Scholar
|